Senior Postdoctoral Scholar Research Associate in Biology and Biological Engineering
Alterations in the gut microbiome are associated with various immune, metabolic, and neurological conditions, including Parkinson’s disease (PD). Exciting new research reveals that the gut microbiome directly impacts symptoms and pathology in PD mouse models. While age is the strongest risk factor for developing PD in humans, I have discovered that the microbiome also ages in PD mice. I propose a bold research program to test if microbiome replacement improves outcomes in PD, transplanting microbiota from young mice into aged animals, and longitudinally assaying behavioral, immune, and pathological endpoints. My work aims to validate the contribution of the gut microbiome to PD-associated phenotypes in mice, develop a framework for future exploration into mechanisms of action, and de-risk novel therapeutic options for PD.